FDA Inspection
Southern California Reproductive Center Medical Group PCSouthern California Reproductive Center Medical Group PC – FDA Inspection, Jul 8, 2025
Record Details
This FDA Inspection record concerns Southern California Reproductive Center Medical Group PC, with an inspection on July 8, 2025, issued by the Los Angeles District Office, covering biologics.
- Inspection Date
- July 8, 2025
- Product Type
- Biologics
View Company Profile
ID · 36b45b02-a333-41e0-b0a7-07c184bf789d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1275017
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.50(a)Determination based on screening and testing
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Southern California Reproductive Center Medical Group PC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 15, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 24, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 6, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 17, 2011 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Southern California Reproductive Center Medical Group PC
- FDA Inspection 1178423 - 2022-08-15
- FDA Inspection 1027891 - 2017-08-24
- FDA Inspection 904200 - 2014-11-06
- FDA Inspection 732541 - 2011-06-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.